Although mepolizumab led to a reduction in loss of smell, postnasal drip, and nasal congestion, these results did not reach statistical significance, and the benefit in nasal symptoms normalized after a period of time, except for improvement in olfaction.
← all excerpts
Nasal polyps in patients with asthma: prevalence, impact, and management challenges.
1
—
—